CN106565762B - 一种原位产生近红外荧光的bodipy类染料及其制备和应用 - Google Patents
一种原位产生近红外荧光的bodipy类染料及其制备和应用 Download PDFInfo
- Publication number
- CN106565762B CN106565762B CN201611010907.1A CN201611010907A CN106565762B CN 106565762 B CN106565762 B CN 106565762B CN 201611010907 A CN201611010907 A CN 201611010907A CN 106565762 B CN106565762 B CN 106565762B
- Authority
- CN
- China
- Prior art keywords
- bodipy
- compound
- situ
- formula
- infrared fluorescent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000975 dye Substances 0.000 title claims abstract description 29
- 238000011065 in-situ storage Methods 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 47
- 150000001875 compounds Chemical class 0.000 claims description 43
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 38
- 238000006243 chemical reaction Methods 0.000 claims description 30
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 28
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 24
- 229910052757 nitrogen Inorganic materials 0.000 claims description 19
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 14
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 14
- 229910052763 palladium Inorganic materials 0.000 claims description 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 10
- GPAYUJZHTULNBE-UHFFFAOYSA-N diphenylphosphine Chemical compound C=1C=CC=CC=1PC1=CC=CC=C1 GPAYUJZHTULNBE-UHFFFAOYSA-N 0.000 claims description 7
- 238000002372 labelling Methods 0.000 claims description 7
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Natural products P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical group C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 claims description 5
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims description 5
- 235000010290 biphenyl Nutrition 0.000 claims description 4
- 239000004305 biphenyl Substances 0.000 claims description 4
- 125000006267 biphenyl group Chemical group 0.000 claims description 4
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 4
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- 239000000090 biomarker Substances 0.000 abstract description 5
- 238000006862 quantum yield reaction Methods 0.000 abstract description 3
- DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical compound C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 abstract description 2
- 230000021615 conjugation Effects 0.000 abstract description 2
- 125000000950 dibromo group Chemical group Br* 0.000 abstract description 2
- 238000003384 imaging method Methods 0.000 abstract description 2
- 239000003550 marker Substances 0.000 abstract description 2
- 239000002243 precursor Substances 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 36
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 9
- 238000005160 1H NMR spectroscopy Methods 0.000 description 9
- 238000012512 characterization method Methods 0.000 description 9
- 239000003480 eluent Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- -1 Phenyl Chemical group 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- 239000003208 petroleum Substances 0.000 description 5
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- URYYVOIYTNXXBN-OWOJBTEDSA-N trans-cyclooctene Chemical compound C1CCC\C=C\CC1 URYYVOIYTNXXBN-OWOJBTEDSA-N 0.000 description 3
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 2
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- OTEKOJQFKOIXMU-UHFFFAOYSA-N 1,4-bis(trichloromethyl)benzene Chemical compound ClC(Cl)(Cl)C1=CC=C(C(Cl)(Cl)Cl)C=C1 OTEKOJQFKOIXMU-UHFFFAOYSA-N 0.000 description 1
- HCPDVOHGFWXGGY-UHFFFAOYSA-N CC1C(NC)=C(C)SC1O Chemical compound CC1C(NC)=C(C)SC1O HCPDVOHGFWXGGY-UHFFFAOYSA-N 0.000 description 1
- 241001062009 Indigofera Species 0.000 description 1
- DKGYESBFCGKOJC-UHFFFAOYSA-N Nc1c[s]cc1 Chemical compound Nc1c[s]cc1 DKGYESBFCGKOJC-UHFFFAOYSA-N 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/022—Boron compounds without C-boron linkages
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B57/00—Other synthetic dyes of known constitution
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
- C09K2211/1055—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with other heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1074—Heterocyclic compounds characterised by ligands containing more than three nitrogen atoms as heteroatoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Materials Engineering (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
本发明公开了一种原位产生近红外荧光的BODIPY类染料及其制备和应用。该染料的结构式为
Description
技术领域
本发明属于生物分子标记技术领域,具体涉及一种能原位产生近红外荧光的BODIPY类荧光染料,以及该染料的制备方法和其在生物分子标记中的应用。
背景技术
现有的能原位产生荧光的生物标记染料如:荧光素、硅罗丹明、罗丹明、香豆素等,这些荧光染料可用于细胞标记、糖代谢标记,但都有其缺点,不算完美的生物标记染料。例如荧光素作为生物标记染料时,其发射波长只有517nm,“turn on”倍数只有34倍(Shieh P,et.al,J.Am.Chem.Soc.2012,134,17428-17431);硅罗丹明作为标记染料时,其发射波长能达到668nm,“turn on”倍数也只有48倍(Shieh P,et.al,5456–5461|PNAS|April 15,2014|vol.111|no.15);罗丹明作为标记染料时,其发射波长为573nm,“turn on”倍数为76倍(Yang J.,et.al,Angew.Chem.Int.Ed.,2014,53,5805–5809);香豆素作为标记染料时,虽然“turn on”倍数能达到900~1600倍,但其发射波长只有505nm(Meimetis L G,et.al,Angew.Chem.Int.Ed.2014,53,7531–7534)。这些染料荧光能到近红外区域的“turn on”倍数不高,这样标记效果不好,“turn on”倍数能做得比较好的但发射波长又不够长,这样对细胞伤害比较大。
BODIPY类染料由于其荧光量子产率高,其荧光范围随不同取代基变化很大,稳定性又很好,它的性能受到普遍公认。
发明内容
本发明所要解决的技术问题在于提供一种用于生物正交反应的原位产生近红外荧光的BODIPY类染料,以及该染料的制备方法和应用。
解决上述技术问题所采用的技术方案是该原位产生近红外荧光的BODIPY类染料的结构式如下所示:
式中R代表苯基,R1代表C1~C4烷基或C1~C2烷氧基取代的苯基,R2代表H或甲基,R3代表甲基、其中R4~R10各自独立的代表H、C1~C4烷氧基或CnH2n+1COO,R11代表H、C1~C4烷氧基或CnH2n+1COO、COOH或CONH2,n为1~4的整数。
上述原位产生近红外荧光的BODIPY染料,优选R代表苯基,R1代表甲基或4-甲氧基苯基,R2代表H或甲基,R3代表甲基、
上述R代表苯基、R1代表C1~C4烷基或C1~C2烷氧基取代的苯基、R2代表H或甲基、R3代表时,该原位产生近红外荧光的BODIPY染料的制备方法由下述步骤组成:
1、以乙腈为溶剂,在氮气保护下,将式1化合物与化合物a或苯乙炔按摩尔比为1:(1.5~2.5),室温搅拌反应10~12小时,分离纯化产物,得到式2化合物。
2、以甲苯为溶剂,在氮气保护下,将式2化合物、化合物c、醋酸钯、2,2-双(二苯基膦)-1,1-联萘、碳酸铯按摩尔比为1:(1~1.5):(0.03~0.1):(0.05~0.1):(0.1~0.2),在50~60℃下搅拌反应20~60分钟,分离纯化产物,得到原位产生近红外荧光的BODIPY染料。
上述R代表苯基、R1代表C1~C4烷基或C1~C2烷氧基取代的苯基、R2代表H或甲基、R3代表时,该原位产生近红外荧光的BODIPY染料的制备方法由下述步骤组成:
1、以甲苯为溶剂,在氮气保护下,将式1化合物与化合物b、醋酸钯、2,2-双(二苯基膦)-1,1-联萘、碳酸铯按摩尔比为1:(1~1.5):(0.05~0.2):(0.1~0.2):(1~2),室温搅拌反应30分钟,分离纯化产物,得到式2化合物。
2、以甲苯为溶剂,在氮气保护下,将式2化合物、化合物c、醋酸钯、2,2-双(二苯基膦)-1,1-联萘、碳酸铯按摩尔比为1:(1~1.5):(0.05~0.2):(0.1~0.2):(1~2),在50~60℃下搅拌反应20~60分钟,分离纯化产物,得到原位产生近红外荧光的BODIPY染料。
上述R1、R2、R3均代表甲基时,该原位产生近红外荧光的BODIPY染料的制备方法为:以甲苯为溶剂,在氮气保护下,将式5化合物、3-苯基-6苯胺-1,2,4,5-四嗪、醋酸钯、2,2’-双(二苯基膦)-1,1’-联萘、碳酸铯按摩尔比为1:(1~1.5):(0.05~0.2):(0.1~0.2):(1~2),在50~60℃下搅拌反应20~60分钟,分离纯化产物,得到原位产生近红外荧光的BODIPY染料。
本发明原位产生近红外荧光的BODIPY染料在生物分子标记中的应用。
本发明相对于现有技术具有以下有益效果:
本发明从已知的二溴BODIPY出发,通过两步偶联,在BODIPY的2,2′-位引入不同基团,增加共轭,首次将四嗪引入BODIPY母体结构中,得到原位产生近红外荧光的BODIPY类染料,其有642nm的荧光发射,超过1000倍的荧光“turn on”,荧光量子产率达到0.3,从而更加彻底的淬灭BODIPY的荧光,当做生物标记时可以做到无背景标记,无背景的细胞成像。
附图说明
图1是实施例1制备的BODIPY染料的荧光发射光谱图。
图2是实施例2制备的BODIPY染料的荧光发射光谱图。
图3是实施例3制备的BODIPY染料的荧光发射光谱图。
图4是实施例4制备的BODIPY染料的荧光发射光谱图。
图5是实施例5制备的BODIPY染料的荧光发射光谱图。
图6是实施例4制备的BODIPY染料与A549细胞标记效果图。
具体实施方式
下面结合附图和实施例对本发明进一步详细说明,但本发明的保护范围不仅限于这些实施例。
实施例1
1、在氮气保护及室温搅拌下,将10μL(0.0878mmol)苯胺滴加到2mL含有25mg(0.0438mmol)式1-1化合物的乙腈溶液中,滴加完后室温搅拌12小时,停止反应,减压浓缩除去乙腈,柱层析分离(洗脱剂为石油醚与乙酸乙酯的体积比为5:1的混合液),得到红色固体式2-1化合物11.2mg,其收率为57%,反应方程式如下所示:
所得产物的结构表征数据为:1H NMR(400MHz,CDCl3)δ:3.88(s,3H),6.35-6.36(d,J=3.88Hz,1H),6.43-6.45(d,J=4.8Hz,1H),6.94-6.95(d,J=4.92Hz,1H),6.98-7.01(m,2H),7.24-7.26(m,4H),7.30-7.44(m,3H),8.12(s,1H);13C NMR(100MHz,CDCl3)δ:55.43,111.66,113.87,116.78,117.29,122.07,122.50,126.00,126.17,129.82,131.73,133.40,135.54,137.39,158.76,160.80。
2、在氮气保护下,向10mL反应试管中加入8.5mg(0.019mmol)式2-1化合物、5.7mg(0.028mmol)3-苯基-6苯胺-1,2,4,5-四嗪、0.2mg(0.00095mmol)醋酸钯、0.8mg(0.00142mmol)2,2’-双(二苯基膦)-1,1’-联萘(BINAP)、8.5mg(0.00266mmol)碳酸铯、5mL干燥的甲苯,在60℃下搅拌反应30分钟后停止反应,用硅胶板分离纯化(洗脱剂为二氯甲烷与石油醚的体积比为1:1的混合液),得到蓝色固体,即式3-1所示的BODIPY染料7.6mg,其收率为74%,反应方程式如下所示:
所得产物的结构表征数据为:1H NMR(400MHz,CDCl3)δ:3.9(s,3H),6.32-6.33(d,J=2.92Hz,1H),6.43-6.44(d,J=2.72Hz,1H),7.71-7.72(d,J=2.68Hz,1H),6.81-6.82(d,J=2.88Hz,1H),7.00-7.0(d,J=5.56Hz,2H),7.15-7.18(m,1H),7.39-7.40(m,4H),7.47-7.46(d,J=5.52Hz,2H),7.61-7.68(m,5H),8.65-8.63(d,J=5.36Hz,4H);13C NMR(100MHz,CDCl3)δ:55.43,103.83,106.16,113.77,118.16,120.89,124.44,125.01,126.65,127.77,129.27,131.29,131.72,132.04,132.40,138.89,144,37,148.26,154.28,160.62,163.47。
实施例2
1、在氮气保护及室温搅拌下,将5.78μL(0.052mmol)苯乙炔滴加到2mL含有20mg(0.0439mmol)式1-1化合物的乙腈溶液中,滴加完后室温搅拌2小时,停止反应,减压浓缩除去乙腈,柱层析分离(洗脱剂为甲苯),得到红色固体式2-2化合物11mg,其收率为68%,反应方程式如下所示:
所得产物的结构表征数据为:1H NMR(400MHz,CDCl3)δ:3.9(s,3H)6.53-6.54(d,J=4.28Hz,1H),6.72-6.73(d,J=4.32Hz,1H),6.82-6.83(d,J=4.24Hz,1H),6.91-6.90(d,J=4.24Hz,1H),7.03-7.05(m,2H),7.37-7.39(m,2H),7.49-7.47(m,2H),7.69-7.66(m,2H);13C NMR(100MHz,CDCl3)δ:161.96,142.79,137.77,136.12,135.79,132.35,131.47,130.97,130.70,129.60,129.04,128.40,125.63,123.97,122.13,114.13,102.38,82.78,55.55。
2、在氮气保护下,向10mL反应试管中加入8.5mg(0.023mmol)式2-2化合物、5.7mg(0.028mmol)3-苯基-6苯胺-1,2,4,5-四嗪、0.4mg(0.0023mmol)醋酸钯、1.8mg(0.0035mmol)2,2’-双(二苯基膦)-1,1’-联萘、8.5mg(0.0322mmol)碳酸铯、5mL干燥的甲苯,在60℃下搅拌反应20分钟后停止反应,用硅胶板分离纯化(洗脱剂为二氯甲烷与石油醚的体积比为1:1的混合液),得到蓝色固体,即式3-2所示的BODIPY染料12mg,其收率为74%,反应方程式如下所示:
所得产物的结构表征数据为:1H NMR(400MHz,CDCl3)δ:3.9(s,3H),6.59-6.60(d,J=4Hz,1H),6.64-6.66(m,2H),7.01-7.04(m,3H),7.35-7.37(d,J=7.08Hz,2H),7.45-7.51(m,4H),7.62-7.66(m,5H),8.37(s,1H),8.64-8.66(m,2H),8.70-8.72(m,2H);13C NMR(100MHz,CDCl3)δ:163.76,163.15,160.94,156.76,141.80,135.14,134.37,133.33,132.67,131.85,131.77,131.76,129.55,129.30,128.50,128.28,128.19,127.92,126.36,123.08,123.00,121.33,120.85,113.88,111.04,96.65,83.10,55.42。
实施例3
1、在氮气保护及室温搅拌下,将7mg(0.045mmol)式a-1化合物滴加到2mL含有21mg(0.045mmol)式1-1化合物的乙腈溶液中,滴加完后室温搅拌12小时,停止反应,减压浓缩除去乙腈,柱层析分离(洗脱剂为石油醚与乙酸乙酯的体积比为5:1的混合液),得到红色固体式2-3化合物11mg,其收率为52%,反应方程式如下所示:
所得产物的结构表征数据为:1H NMR(400MHz,CDCl3)δ:3.88(s,3H),3.92(s,3H),6.37-6.38(d,J=3.92Hz,1H),6.49-6.50(d,J=3.92Hz,1H),6.55-6.54(d,J=4.88Hz,1H),6.98-7.01(m,3H),7.29-7.27(m,2H),7.42-7.40(d,J=8.64Hz,2H),8.07-8.09(d,J=8.6Hz,2H),8.21(s,1H);13C NMR(100MHz,CDCl3)δ:166.12,161.02,156.96,141.72,135.47,135.27,134.03,132.53,131.77,131.44,126.75,125.73,123.54,120.44,117.96,113.91,111.01,55.42,52.19。
2、在氮气保护下,向10mL反应试管中加入4.5mg(0.009mmol)的式2-3化合物、2.7mg(0.011mmol)3-苯基-6苯胺-1,2,4,5-四嗪、1mg(0.0023mmol)醋酸钯、4mg(0.0035mmol)2,2’-双(二苯基膦)-1,1’-联萘、4mg(0.0322mmol)碳酸铯、2mL干燥的甲苯,在60℃下搅拌反应20分钟后停止反应,用硅胶板分离纯化(洗脱剂为纯二氯甲烷),得到蓝色固体,即式3-3所示的BODIPY染料3.1mg,其收率为52%,反应方程式如下所示:
所得产物的结构表征数据为:1H NMR(400MHz,CDCl3)δ:3.90(s,3H),3.92(s,3H),6.42-6.41(d,J=4.44Hz,1H),6.49-6.48(d,J=4.44Hz,1H),6.82-6.79(m,2H),7.03-70.1(d,J=8.88Hz,2H),7.23(m,1H),7.42-7.40(d,J=8.8Hz,2H),7.48-7.46(m,2H),7.63-7.61(m,3H),7.78(s,1H),7.71(s,1H),8.05-8.03(d,J=8.68Hz,2H),8.67-8.63(m,4H);13CNMR(150MHz,CDCl3)δ:166.50,163.38,160.81,150.39,150.79,143.65,143.58,132.49,131.96,131.75,131.45,129.86,129.65,129.28,127.83,126.41,125.90,124.47,118.91,118.06,113.85,105.36,55.43,52.00。
实施例4
1、在氮气保护下,向10mL反应试管中加入15mg(0.0329mmol)式1-1化合物、3.4mg(0.0219mmol)式b-2化合物、0.5mg(0.00219mmol)醋酸钯、2mg(0.00329mmol)2,2’-双(二苯基膦)-1,1’-联萘、10mg(0.0307mmol)碳酸铯、2mL干燥的甲苯,在60℃下搅拌反应20分钟后停止反应,用硅胶板分离纯化(洗脱剂为二氯甲烷与甲苯的体积比为1:2的混合液),得到红色固体式2-4化合物7.9mg,其收率为68%,反应方程式如下所示:
所得产物的结构表征数据为:1H NMR(600MHz,CDCl3)δ:7.54(d,J=5.4Hz,1H),7.42(d,J=8.6Hz,2H),7.22(d,J=5.4Hz,1H),7.18(d,J=7.1Hz,2H),7.00(t,J=6.0Hz,3H),6.57(d,J=4.8Hz,1H),6.52(d,J=3.9Hz,1H),6.38(d,J=3.9Hz,1H),4.00(d,J=2.8Hz,3H),3.89(s,3H);13C NMR(100MHz,CDCl3)δ:163.28,160.99,155.69,143.03,136.02,135.23,134.08,132.33,131.77,125.77,124.00,119.99,119.82,118.17,113.84,112.91,110.99,55.39,53.40。
2、在氮气保护下,向10mL反应试管中加入4.5mg(0.00827mmol)式2-4化合物、2.5mg(0.01mmol)3-苯基-6苯胺-1,2,4,5-四嗪、1mg(0.00413mmol)醋酸钯、4mg(0.0062mmol)2,2’-双(二苯基膦)-1,1’-联萘、4mg(0.012mmol)碳酸铯、2mL干燥的甲苯,在60℃下搅拌反应20分钟后停止反应,用硅胶板分离纯化(洗脱剂为二氯甲烷与甲苯的体积比为1:1的混合液),得到蓝色固体,即式3-4所示的BODIPY染料1.6mg,其收率为52%,反应方程式如下所示:
所得产物的结构表征数据为:1H NMR(600MHz,CDCl3)δ:8.70-8.62(m,4H),7.64-7.60(m,3H),7.49(t,J=7.1Hz,2H),7.48-7.45(m,3H),7.29(t,J=4.6Hz,3H),7.02(d,J=8.6Hz,3H),6.83(d,J=4.7Hz,2H),6.77(d,J=4.4Hz,1H),6.49(d,J=4.5Hz,1H),6.35(d,J=4.4Hz,1H),3.94(s,1H),3.90(s,3H);13C NMR(150MHz,CDCl3)δ:164.37,163.40,160.70,151.35,149.32,146.43,143.56,135.37,132.48,132.01,131.90,131.76,130.90,130.09,129.56,129.28,129.02,128.84,127.84,126.55,126.16,119.61,119.51,113.79,65.56,55.43。
实施例5
在氮气保护下,向10mL反应试管中加入6.4mg(0.024mmol)的式5-1(已知)化合物、7.1mg(0.028mmol)3-苯基-6苯胺-1,2,4,5-四嗪、0.5mg(0.0024mmol)醋酸钯、2.5mg(0.0036mmol)2,2’-双(二苯基膦)-1,1’-联萘、11mg(0.036mmol)碳酸铯、2mL干燥的甲苯,在60℃下搅拌反应30分钟后停止反应,用硅胶板分离纯化(洗脱剂为二氯甲烷:石油醚=1.5:1),得到暗红色固体,即式5-2所示的BODIPY染料mg,其收率为52%,反应方程式如下所示:
所得产物的结构表征数据为:1H NMR(600MHz,CDCl3)δ:8.72-8.54(m,4H),7.94(s,1H),7.72-7.54(m,3H),7.41(d,J=8.8Hz,2H),6.52(d,J=4.6Hz,1H),6.04(s,1H),2.52(m,6H),2.41(s,3H);13C NMR(150MHz,CDCl3)δ:163.70,163.30,152.89,150.14,143.30,135.25,132.55,131.98,129.60,129.30,129.32,127.89,126.43,119.64,106.52,29.71。
发明人分别将实施例1~5制备的BODIPY染料溶于DMF中,配成1mmol/L的BODIPY染料溶液,取10μL BODIPY染料溶液加入2.5mL pH=7.4的磷酸缓冲液与DMF的体积比为1:1的混合液中,扫其发射光谱,结果如图1~5所示。由图1~5中的反应前发射光谱曲线可见,在发生点击化学之前基本上没有荧光,此时向比色皿中加入100μL 1mmol/L反式环辛烯(TCO),发生“点击”化学后,染料释放出荧光(见图1~5中的反应后发射光谱曲线)。由此可知,本发明的BODIPY染料是可以原位产生荧光的。
发明人将用磷脂修饰过的反式环辛烯加入到细胞培养液中,用此培养液来液培养细胞30分钟后,将10μL 1mmol/L实施例4的BODIPY染料溶液加入细胞培养皿中,立马到共聚焦显微镜下拍照,得到如图6所示照片。由图6可见,该BODIPY染料是可以用于细胞标记的。
Claims (5)
1.一种原位产生近红外荧光的BODIPY染料,其特征在于该染料的结构式如下所示:
式中R代表苯基,R1代表甲基或4-甲氧基苯基,R2代表H或甲基,R3代表甲基、
2.一种权利要求1所述的原位产生近红外荧光的BODIPY染料的制备方法,其中R3代表 其特征在于它由下述步骤组成:
(1)以乙腈为溶剂,在氮气保护下,将式1化合物与化合物a或苯乙炔按摩尔比为1:(1.5~2.5),室温搅拌反应10~12小时,分离纯化产物,得到式2化合物;
(2)以甲苯为溶剂,在氮气保护下,将式2化合物、化合物c、醋酸钯、2,2-双(二苯基膦)-1,1-联萘、碳酸铯按摩尔比为1:(1~1.5):(0.03~0.1):(0.05~0.1):(0.1~0.2),在50~60℃下搅拌反应20~60分钟,分离纯化产物,得到原位产生近红外荧光的BODIPY染料;
3.一种权利要求1所述的原位产生近红外荧光的BODIPY染料的制备方法,其中R3代表其特征在于它由下述步骤组成:
(1)以甲苯为溶剂,在氮气保护下,将式1化合物与化合物b、醋酸钯、2,2-双(二苯基膦)-1,1-联萘、碳酸铯按摩尔比为1:(1~1.5):(0.05~0.2):(0.1~0.2):(1~2),室温搅拌反应30分钟,分离纯化产物,得到式2化合物;
(2)以甲苯为溶剂,在氮气保护下,将式2化合物、化合物c、醋酸钯、2,2-双(二苯基膦)-1,1-联萘、碳酸铯按摩尔比为1:(1~1.5):(0.05~0.2):(0.1~0.2):(1~2),在50~60℃下搅拌反应20~60分钟,分离纯化产物,得到原位产生近红外荧光的BODIPY染料;
4.权利要求1所述的原位产生近红外荧光的BODIPY染料的制备方法,其中R1、R2、R3均代表甲基,其特征在于:以甲苯为溶剂,在氮气保护下,将式5化合物、化合物c、醋酸钯、2,2’-双(二苯基膦)-1,1’-联萘、碳酸铯按摩尔比为1:(1~1.5):(0.05~0.2):(0.1~0.2):(1~2),在50~60℃下搅拌反应20~60分钟,分离纯化产物,得到原位产生近红外荧光的BODIPY染料;
5.权利要求1所述的原位产生近红外荧光的BODIPY染料在生物分子标记中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611010907.1A CN106565762B (zh) | 2016-11-17 | 2016-11-17 | 一种原位产生近红外荧光的bodipy类染料及其制备和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611010907.1A CN106565762B (zh) | 2016-11-17 | 2016-11-17 | 一种原位产生近红外荧光的bodipy类染料及其制备和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106565762A CN106565762A (zh) | 2017-04-19 |
CN106565762B true CN106565762B (zh) | 2018-10-23 |
Family
ID=58542182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611010907.1A Expired - Fee Related CN106565762B (zh) | 2016-11-17 | 2016-11-17 | 一种原位产生近红外荧光的bodipy类染料及其制备和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106565762B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109234759B (zh) * | 2018-11-02 | 2019-10-25 | 陕西师范大学 | 一种bodipy的合成方法 |
CN110128455B (zh) * | 2019-05-10 | 2021-10-15 | 南京林业大学 | 一种冰片酯基苯乙炔基BODIPY类pH荧光探针的制备方法 |
CN113912632B (zh) * | 2021-11-10 | 2023-11-17 | 四川大学华西医院 | 一种氟硼荧光染料及其制备方法和用途 |
CN114106027B (zh) * | 2021-11-10 | 2023-11-17 | 四川大学华西医院 | 一种氟硼荧光染料-四嗪类荧光探针及其制备方法和用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2852664B1 (en) * | 2012-05-18 | 2017-09-06 | Medical Research Council | Methods of incorporating an amino acid comprising a bcn group into a polypeptide using an orthogonal codon encoding it and an orthorgonal pylrs synthase. |
WO2014182704A2 (en) * | 2013-05-06 | 2014-11-13 | The General Hospital Corporation | Bioorthogonal turn-on probes |
-
2016
- 2016-11-17 CN CN201611010907.1A patent/CN106565762B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN106565762A (zh) | 2017-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106565762B (zh) | 一种原位产生近红外荧光的bodipy类染料及其制备和应用 | |
CN106565606B (zh) | 具有聚集诱导发光性质的化合物及其制备方法和用途 | |
CN106083824B (zh) | 有机光电材料以及包括该有机材料的有机电致发光器件 | |
CN102239230A (zh) | 光敏组合物和用所述组合物制得的电子器件 | |
Adil et al. | Effects of incorporating regioisomers and flexible rotors to direct aggregation induced emission to achieve stimuli-responsive luminogens, security inks and chemical warfare agent sensors | |
CN105820152B (zh) | 2,2’-二芳基-3,3’-联二噻吩衍生物、合成方法及其应用 | |
CN107163080B (zh) | 刺激响应三苯乙烯类光致变色材料及其合成方法与应用 | |
CN104447744A (zh) | 苝二酰亚胺衍生物、及其在太阳能电池的应用及制备方法 | |
CN105820151B (zh) | 2, 2’-二(苯乙烯基)- 3, 3’-联二噻吩衍生物、合成方法及其应用 | |
CN109369834B (zh) | 一种具有多重刺激响应性的aiee侧链型聚合物发光材料及其制备方法和应用 | |
Kong et al. | Development of dimeric triarylmethine derivatives with improved thermal and photo stability for color filters | |
CN110156749A (zh) | 一种非对称9,10-双噻吩基蒽荧光化合物及其制备方法和应用 | |
CN107459488B (zh) | 异长叶烷基并嘧啶-2-胺席夫碱类荧光化合物及其制备方法 | |
CN103936732B (zh) | 1,7-二氰基修饰的苝酰亚胺的衍生物及其制备方法 | |
Jung et al. | Development of cross-linkable dimeric triarylmethine derivatives with improved thermal and solvent stability for color filters | |
CN104356055B (zh) | 一种二氢吡啶类衍生物及其合成方法与用途 | |
CN110105373B (zh) | 一种基于吡啶喹喔啉双柱[n]芳烃的纳米粒子及其制备方法与应用 | |
CN108410202A (zh) | 一种喹啉七甲川菁染料的制备方法 | |
CN114874145A (zh) | 一种水溶性三苯甲基类自由基材料及其制备方法和应用 | |
WO2023065501A1 (zh) | 一种聚集诱导发光荧光染料MG-Rho及其制备方法和应用 | |
CN104672230A (zh) | 含芳胺基的芴类衍生物及其在电致发光器件中的应用 | |
CN109232520A (zh) | 5,5’-二(苯乙烯基)-3,3’-联二噻吩衍生物、合成方法及其应用 | |
CN111574538A (zh) | 一种d-a型近红外有机发光材料及其制备方法与应用 | |
CN109705147B (zh) | 一种环境敏感染料及其制备方法和应用 | |
CN108949160B (zh) | 一种具有荧光性能的芴类有机化合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20181023 Termination date: 20211117 |